(Q38345714)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

title

p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Tung-Tien Sun

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

Jing Gao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Hong-Ying Huang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Joanne Pak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Jin Cheng

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Zhong-Ting Zhang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Ellen Shapiro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Xue-Ru Wu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

language of work or name

English

0 references

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

page(s)

687-696

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

SV40-induced immortalization of human cells

17 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

Genetic studies and molecular markers of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

Can biological markers predict recurrence and progression of superficial bladder cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

Regulation of p53 after different forms of stress and at different cell cycle stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

A tissue-specific promoter that can drive a foreign gene to express in the suprabasal urothelial cells of transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

Tissue-specific inactivation of p53 tumor suppression in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Genetic mechanisms of tumor suppression by the human p53 gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

The role of tetramerization in p53 function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Molecular and immunopathology studies of oncogenes and tumor-suppressor genes in bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Oncogenic ras and p53 cooperate to induce cellular senescence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

What we could do now: molecular pathology of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Bladder caner from a perspective of 40 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

'Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

p53 Expression Predicts Progression and Poor Survival in T1 Bladder Tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Growth factors and bladder cancer: clinical implications of the interactions between growth factors and their urothelial receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Molecular alterations in bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Molecular targeting and pharmacogenomics in the management of advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

p53 and microvessel density in primary resection specimens of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

The p53 tumor suppressor gene: from molecular biology to clinical investigation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207169

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14737103%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

17 November 2019

1045011400

0 references

1 reference